These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 659016)

  • 1. Inhibition of human complement components by Loxosceles reclusa venom.
    Futrell JM; Morgan PN
    Int Arch Allergy Appl Immunol; 1978; 57(3):275-8. PubMed ID: 659016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of complement by Loxosceles reclusa spider venom.
    Gebel HM; Finke JH; Elgert KD; Cambell BJ; Barrett JT
    Am J Trop Med Hyg; 1979 Jul; 28(4):756-62. PubMed ID: 464196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and neutralization of biological activities associated with venom from the brown recluse spider, Loxosceles reclusa.
    Futrell JM; Morgan PN
    Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 1):1206-11. PubMed ID: 596517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro model for studying hemolysis associated with venom from the brown recluse spider (Loxosceles reclusa).
    Futrell JM; Morgan BB; Morgan PN
    Toxicon; 1979; 17(4):355-62. PubMed ID: 494317
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternate complement pathway activation by recluse spider venom.
    Kurpiewski G; Campbell BJ; Forrester LJ; Barrett JT
    Int J Tissue React; 1981 Mar; 3(1):39-45. PubMed ID: 7287056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway.
    Tambourgi DV; Magnoli FC; Von Eickstedt VR; Benedetti ZC; Petricevich VL; da Silva WD
    J Immunol; 1995 Nov; 155(9):4459-66. PubMed ID: 7594608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic and hemolytic properties of brown recluse spider (Loxosceles reclusa) toxin and extracts of venom apparatus, cephalothorax and abdomen.
    Rekow MA; Civello DJ; Geren CR
    Toxicon; 1983; 21(3):441-4. PubMed ID: 6353666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotoxicology of brown recluse spider (Loxosceles reclusa) venom.
    Babcock JL; Marmer DJ; Steele RW
    Toxicon; 1986; 24(8):783-90. PubMed ID: 3775793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation and characterization of venom components in the brown recluse spider (Loxosceles reclusa)--I. Preparative disc electrophoresis.
    Jong YS; Norment BR; Heitz JR
    Toxicon; 1979; 17(3):307-12. PubMed ID: 473245
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysis of human erythrocytes by venom from the brown recluse spider, Loxosceles reclusa.
    Morgan BB; Morgan PN; Bowling RE
    Toxicon; 1978; 16(1):85-8. PubMed ID: 622732
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of antiserum on the systemic response in mice caused by a component isolated from an extract of the brown recluse spider (Loxosceles reclusa) venom apparatus.
    Beckwith ML; Babcock JL; Geren CR
    Toxicon; 1980; 18(5-6):663-6. PubMed ID: 7222071
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of venom from the brown recluse spider (Loxosceles reclusa) on human neutrophils.
    Majeski JA; Stinnett JD; Alexander JW; Durst GG
    Toxicon; 1977; 15(5):423-7. PubMed ID: 906025
    [No Abstract]   [Full Text] [Related]  

  • 13. Partial characterization of lethal and neuroactive components of the brown recluse spider (Loxosceles reclusa) venom.
    Foil LD; Frazier JL; Norment BR
    Toxicon; 1979; 17(4):347-54. PubMed ID: 494316
    [No Abstract]   [Full Text] [Related]  

  • 14. Isotachophoretic and immunological analysis of venoms from sea snakes (Laticauda semifasciata) and brown recluse spiders (Loxosceles reclusa) of different morphology, locality, sex, and developmental stages.
    Kent CG; Tu AT; Geren CR
    Comp Biochem Physiol B; 1984; 77(2):303-11. PubMed ID: 6697691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brown Recluse spider bite mediated hemolysis: clinical features, a possible role for complement inhibitor therapy, and reduced RBC surface glycophorin A as a potential biomarker of venom exposure.
    Gehrie EA; Nian H; Young PP
    PLoS One; 2013; 8(9):e76558. PubMed ID: 24086749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a toxin from brown recluse spider (Loxosceles reclusa) venom gland extracts.
    Babcock JL; Civello DJ; Geren CR
    Toxicon; 1981; 19(5):677-89. PubMed ID: 7302957
    [No Abstract]   [Full Text] [Related]  

  • 17. An inhibitor of complement in the venom of the brown recluse spider, Loxosceles reclusa.
    Kniker WT; Morgan PN; Flanigan WJ; Reagan PW; Dillaha CJ
    Proc Soc Exp Biol Med; 1969 Sep; 131(4):1432-4. PubMed ID: 5812012
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of the brown recluse spider bite.
    Rees R; Shack RB; Withers E; Madden J; Franklin J; Lynch JB
    Plast Reconstr Surg; 1981 Nov; 68(5):768-73. PubMed ID: 7291346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic effect in mice or venom apparatus extract and toxin from the brown recluse spider (Loxosceles reclusa).
    Babcock JL; Suber RL; Frith CH; Geren CR
    Toxicon; 1981; 19(4):463-71. PubMed ID: 7330887
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of brown recluse spider venom on cell membranes: the inciting mechanism?
    Rees RS; Nanney LB; Yates RA; King LE
    J Invest Dermatol; 1984 Oct; 83(4):270-5. PubMed ID: 6481179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.